Article Details

If You're A Risk-Taking Investor, Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Is Worth Taking A ...

Retrieved on: 2021-05-17 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

If You're A Risk-Taking Investor, Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Is Worth Taking A .... View article details on hiswai:

Excerpt

Vanguard Group, Inc. (The), with 2.51% or 1.04 Million shares worth $3.42 Million as of Dec 30, 2020, holds the second largest percentage of ...

Article found on: marketingsentinel.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up